-
ApoRepair
Created in 2023
-
-
Up & running (A)
Existing signals show a regular activity -
Social networks
294 -
Activities
-
Technologies
-
Entity types
-
Location
Halle de l'Innovation, 10 Rue Françoise, 34000 Montpellier, France
Montpellier
France
-
Employees
Scale: 2-10
Estimated: 5
-
SIREN
979575669 -
Engaged catalyst
4
0 0 -
Added in Motherbase
5 months, 2 weeks ago
-
Value proposition
To save more patients from a heart attack
ApoRepair is a French biotech company emerging from the National Center for Scientific Research (CNRS) that aims to improve the management of patients in the acute phase of myocardial infarction (MI). Reperfusion of the heart, essential to save the patient's life, generates adverse effects that diminish the expected benefit. Our therapeutic peptide protects the myocardium and improves the effects of reperfusion. This patented technology is based on a collaborative team effort spanning more than 15 years.
-
Accueil ApoRepair - Aporepair
La start-up Aporepair développe un peptide injecté pendant les angioplasties permettant de diminuer leurs effets secondaires.
https://aporepair.fr/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
MAAF Assurances
Insurance, Health, Mutual insurance, Insurance (Auto) |
MAAF Assurances
Insurance, Health, Mutual insurance, Insurance (Auto) |
Other
14 Feb 2026 |
|
|
French Tech Méditerranée
French Tech, Technology, Information and Internet (Auto) |
French Tech Méditerranée
French Tech, Technology, Information and Internet (Auto) |
Other
31 Jan 2026 |
|
|
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Non-profit Organizations (Auto) |
Eurobiomed
Public business cluster, Biotechnology, French Cluster, Non-profit Organizations (Auto) |
Other
13 Jun 2026 |
|
|
Créalia Occitanie
Civic and Social Organizations (Auto) |
Créalia Occitanie
Civic and Social Organizations (Auto) |
Other
30 Sep 2024 |
|
|